Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-10-05 4:45 pm Unchanged | 13D | INOZYME PHARMA INC INZY | Novo Holdings A/S | 2,569,379 11% | 0 (Unchanged) | View |
2020-09-04 4:30 pm Sale | 13G | HARMONY BIOSCIENCES HLDGS INC HRMY | Novo Holdings A/S | 3,754,973 6.6% | -654,830 (-14.85%) | View |
2020-08-25 4:30 pm Purchase | 13G | HARMONY BIOSCIENCES HLDGS INC HRMY | Novo Holdings A/S | 4,409,803 6.9% | 4,409,803 (New Position) | View |
2020-08-14 4:31 pm Purchase | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Novo Holdings A/S | 2,361,229 6.8% | 2,361,229 (New Position) | View |
2020-08-13 4:47 pm Purchase | 13D | CHECKMATE PHARMACEUTICALS, INC CMPI | Novo Holdings A/S | 2,170,100 10.1% | 2,170,100 (New Position) | View |
2020-08-11 4:30 pm Sale | 13G | ENTASIS THERAPEUTICS HLDGS INC ETTX | Novo Holdings A/S | 1,173,896 4.3% | -1,007,947 (-46.20%) | View |
2020-07-29 4:42 pm Purchase | 13D | INOZYME PHARMA INC INZY | Novo Holdings A/S | 2,569,379 11.5% | 2,569,379 (New Position) | View |
2020-07-24 4:30 pm Purchase | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Novo Holdings A/S | 23,048,499 5.5% | 8,888,888 (+62.78%) | View |
2020-07-16 4:35 pm Purchase | 13D | NKARTA INC NKTX | Novo Holdings A/S | 2,793,865 8.59% | 2,793,865 (New Position) | View |
2020-07-09 4:29 pm Sale | 13D | CORVUS PHARMACEUTICALS INC CRVS | Novo Holdings A/S | 1,389,498 4.97% | -1,538,062 (-52.54%) | View |
2020-06-16 1:54 pm Unchanged | 13G | ENTASIS THERAPEUTICS HLDGS INC ETTX | Novo Holdings A/S | 2,181,843 7.99% | 0 (Unchanged) | View |
2020-03-12 1:11 pm Sale | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 2,080,885 8.47% | -353,585 (-14.52%) | View |
2020-02-05 12:58 pm Purchase | 13G | SEASPINE HLDGS CORP COM SPNE | Novo Holdings A/S | 1,658,037 6.41% | 350,000 (+26.76%) | View |
2020-02-05 12:53 pm Unchanged | 13G | INOGEN INC INGN | Novo Holdings A/S | 3,549,320 16.13% | 0 (Unchanged) | View |
2020-02-05 12:49 pm Unchanged | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 3,409,021 13.74% | 0 (Unchanged) | View |
2020-02-05 12:45 pm Unchanged | 13G | ENTASIS THERAPEUTICS HLDGS INC ETTX | Novo Holdings A/S | 2,181,843 16.42% | 0 (Unchanged) | View |
2020-01-17 1:34 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 9.63% | 0 (Unchanged) | View |
2019-11-27 2:31 pm Sale | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 2,434,470 9.9% | -240,000 (-8.97%) | View |
2019-11-14 2:10 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 3,409,021 13.99% | 3,409,021 (New Position) | View |
2019-09-20 11:15 am Unchanged | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 2,674,470 10.92% | 0 (Unchanged) | View |